Company patents

API CORPORATION

API CORPORATION's patent strategy reveals a surprising shift away from its core pharma_biotech categories, with significant declines in Fermentation & Biosynthesis (-100.0% YoY in 2025) and Heterocyclic Compounds (Pharma) (-80.0% YoY in 2025), despite these areas historically constituting a large portion of its portfolio. While Acyclic / Carbocyclic Compounds remains its largest category at 51.9% of its portfolio, its 2025 decline of -57.1% YoY suggests a broader re-evaluation of its chemical synthesis focus.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

27 US filings (since 2023) · 7 categories · 5 themes

Patents

Showing 1-10 of 41

Page 1 of 5